Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Naltrexone, sold under the brand name Revia among others, is a medication primarily used to manage alcohol use and opioid use disorders by reducing cravings and feelings of euphoria associated with substance use disorder. It has also been found to be effective for the treatment of other addictions and may be used for them off-label. The combination…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Naltrexone. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
opioid effects studies may use opioids oral 6β-naltrexol buprenorphine alcohol mg treatment used brain administration antagonist dependence mor also withdrawal
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Naltrexone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Naltrexone | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Naltrexone | ATC code | N07BB04 (WHO) | 1.00 | infobox |
| Naltrexone | Bioavailability | 5–60% | 1.00 | infobox |
| Naltrexone | CAS Number | 16590-41-3 Y | 1.00 | infobox |
| Naltrexone | ChEBI | CHEBI:7465 Y | 1.00 | infobox |
| Naltrexone | ChEMBL | ChEMBL19019 Y | 1.00 | infobox |
| Naltrexone | ChemSpider | 4514524 Y | 1.00 | infobox |
| Naltrexone | CompTox Dashboard (EPA) | DTXSID4046313 | 1.00 | infobox |
| Naltrexone | DrugBank | DB00704 Y | 1.00 | infobox |
| Naltrexone | Duration of action | >72 hours | 1.00 | infobox |
| Naltrexone | ECHA InfoCard | 100.036.939 | 1.00 | infobox |
| Naltrexone | Elimination half-life | Oral (Revia): • Naltrexone: 4 hours • 6β-Naltrexol: 13 hours Oral (Contrave): • Naltrexone: 5 hours IMTooltip Intramuscular injection (Vivitrol): • Naltrexone: 5–10 days • 6β-Na… | 1.00 | infobox |
| Naltrexone | Excretion | Urine | 1.00 | infobox |
| Naltrexone | Formula | C20H23NO4 | 1.00 | infobox |
| Naltrexone | IUPHAR/BPS | 1639 | 1.00 | infobox |
| Naltrexone | KEGG | D05113 Y | 1.00 | infobox |
| Naltrexone | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Naltrexone | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Naltrexone | Legal status | CA: ℞-only | 1.00 | infobox |
| Naltrexone | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Naltrexone | Legal status | US: ℞-only | 1.00 | infobox |
| Naltrexone | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Naltrexone | License data | US DailyMed: Naltrexone | 1.00 | infobox |
| Naltrexone | MedlinePlus | a685041 | 1.00 | infobox |
| Naltrexone | Melting point | 169 °C (336 °F) | 1.00 | infobox |
| Naltrexone | Metabolism | Liver (non-CYP450) | 1.00 | infobox |
| Naltrexone | Metabolites | 6β-Naltrexol, others | 1.00 | infobox |
| Naltrexone | Molar mass | 341.407 g·mol−1 | 1.00 | infobox |
| Naltrexone | Onset of action | 30 minutes | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.